Drug: |
AUY922 |
|||
---|---|---|---|---|
Trial: |
Phase I-II Study to Determine the Maximum Tolerated Dose (MTD) of AUY922 in Advanced Solid Malignancies, and Efficacy in HER2+ or ER+ Locally Advanced or Metastatic Breast Cancer Patients. |
|||
Conditions: | Solid Tumors | |||
Trial Status: |
Ongoing, but not recruiting |
Washington University School of Medicine660 S. Euclid Ave |
Principal Investigator: |
Timothy Pluard, MD |
---|---|
Contact: |
800-600-3606 info@ccadmin.wustl.edu |
Activation Status of this Site: |
Closed |
Notes about this Site: |
|
Washington University School of Medicine Website: |
http://www.siteman.wustl.edu/FindProtocol.aspx?id=625&mid=70 |
Use the plus (+) and minus (-) controls to zoom in/out.
Click and drag the map or use the arrows to move (pan) the map.
Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.